The immediate future for the medical treatment of atrial fibrillation

Author： Pedersen Ole Dyg   Brendorp Bente   Køber Lars   Torp-Pedersen Christian  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.7, Iss.2, 2002-10, pp. : 259-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation, Atrial Fibrillation and Cardiac Surgery: Current Medical and Invasive Approaches for the Treatment of Atrial Fibrillation

By  

Current Pharmaceutical Design, Vol. 24, Iss. 3, 2018-04 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite

Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-03 ,pp. : 1011-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Approaches in the Treatment of Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 13-28

Bentham Science Publishers

Access to resources Recommend Favorite

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

By Doggrell Sheila A   Hancox Jules C  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 867-871

Informa Healthcare

Access to resources Recommend Favorite

Assessment of Quality of Life in Pharmacological Treatment of Atrial Fibrillation

By  

Heart Drug, Vol. 3, Iss. 1, 2003-07 ,pp. : 14-24

Karger

Access to resources Recommend Favorite